Cardiac Resynchronization Therapy in Heart Failure: Rationale, Results, Indications, Limits and Perspectives
Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2014, Vol 1, Issue 1
Abstract
Heart Failure is the result of heterogeneous structural heart diseases, especially ischemic disease, and is becoming increasingly common in all Western countries. Many patients continue to be symptomatic in spite of progress in pharmacological therapy, and the risk of mortality remains high in the most advanced functional classes. Cardiac resynchronization therapy can be used as a therapeutic strategy for alleviating symptoms and reducing mortality in selected patients with heart failure. Cardiac resynchronization therapy provides both immediate and medium/long-term results. The immediate results are the reduced QRS duration, the synchrony restoration between the ventricles and between the lateral and septal walls of the left ventricle, the reduced mitral regurgitation and the increased stroke volume. In the medium/long term, left ventricular reverse remodeling occurs and left ventricular ejection fraction is increased. Several trials have documented both increased functional capacity and improvements in quality of life and New York Heart Association class. Moreover, cardiac resynchronization therapy has been seen to reduce HF hospitalizations and mortality and the total number of days of hospitalization. In order to reduce the percentage of non-responders to cardiac resynchronization therapy, it is necessary to optimize the prognostic stratification of candidates for implantation through multi-parameter evaluations and to ensure correct device programming with periodic updates which are widely recommended but not so often performed. Whether indications should be extended will need to be evaluated in view of the known complications mainly associated with lead implantation.
Authors and Affiliations
Andrea Andrea, Sergio Valsecchi, Umberto Riva, Maria Grazia Bendini, Massimo Leggio
Keywords
Related Articles
- EP ID EP231469
- DOI 10.17352/2455-2976.000004
- Views 124
- Downloads 0
Progression in Diagnosis and Treatment of Resistant Hypertension
Introduction: Resistant Hypertension (RH) is a major risk factor of numerous diseases. RH is a challenging clinical prob-lem,many factors affect blood pressure (BP) control. Correct diagnosis and appropriate drug therapy...
Disparity between estimates and measures of maximum heart rate in pilots with coronary artery disease
Background : Several studies indicate that HRmax estimates using the traditional equation, HRmax = 220 - Age, may represent a regression slope and intercept that does reflect the true relationship between age and maximal...
Home Monitoring of Implantable Remote Loop Recorders Expedites Intervention
A70 year old woman had a Reveal LINQ (Medtronic, Minneapolis, MN, USA) implantable loop recorder (ILR) implanted to investigate a cardiac cause of syncope.Due to the ability of this device to utilise home monitoring, ear...
Infective Endocardatis at the Yaounde General Hospital: Clinical aspects and outcome (Case Series)
Introduction: Infectious endocarditis (IE) is a severe pathology. Its epidemiological, clinical and evolutive profile varies a lot depending if it is in the context of a developed country or developing country. In our co...
Aortic Valve Thrombosis in Antiphospholipid Syndrome Causing Coronary Artery Embolic Disease
Antiphospholipid syndrome (APS) is a disorder characterized by the presence of antiphospholipid antibodies which are known to promote thrombus formation and heart valve complications. In this case, a 20 year old African...